Lymphoma: By: Angel R. Aggabao
Lymphoma: By: Angel R. Aggabao
Lymphoma: By: Angel R. Aggabao
Lymphoma
• For all lymphomas combined, prevalence ranged
from 48.0 (95% CI 45.8–50.3) per 100 000
Incidence population within 3 years of diagnosis, through to
72.5 (95% CI 69.7–75.3) per 100 000 within 5 years
and 123.7 (95% CI 120.0–127.4) within 10 years.
Pathophysiology
• Enlarged lymph nodes
• Chills
• Weight loss
• Fatigue (feeling very tired)
• CD20
• Cancer type: Non-Hodgkin lymphoma
What's analyzed: Blood
How used: To determine whether treatment with a targeted therapy is appropriate
• Lactate dehydrogenase
• Cancer types: Germ cell tumors, lymphoma, leukemia, melanoma, and neuroblastoma
What's analyzed: Blood
How used: To assess stage, prognosis, and response to treatment
• Programmed death ligand 1 (PD-L1)
• Cancer types: Non-small cell lung cancer, liver cancer, stomach cancer, gastroesophageal junction
cancer, classical Hodgkin lymphoma, and other aggressive lymphoma subtypes
What's analyzed: Tumor
How used: To determine whether treatment with a particular type of targeted therapy is appropriate
• T-cell receptor gene rearrangement
• Cancer type: T-cell lymphoma
What's analyzed: Bone marrow, tissue, body fluid, blood
How used: To help in diagnosis; sometimes to detect and evaluate residual disease
Diagnostic Test
• bone marrow aspiration and biopsy, lumbar puncture, chest x-ray, body
CT, PET, bone scan, body MRI or abdominal ultrasound may be used to
look for enlarged lymph nodes throughout the body
and determine whether the lymphoma has spread.
Medical Intervention
• Non-Surgical
• Surgical